The invention relates to novel pharmaceutical compounds and their use in the treatment of cancer or an autoimmune disease in a human, more specifically breast cancer, gastric cancer, ovarian cancer, lung cancer, colon cancer, rectal cancer, colorectal cancer or esophageal cancer. The invention further relates to pharmaceutical compositions comprising these compounds.